163 related articles for article (PubMed ID: 3121844)
41. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
Welch WJ; Wilcox CS; Dunbar KR
Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
[TBL] [Abstract][Full Text] [Related]
42. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
Reyes AA; Klahr S
Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
[TBL] [Abstract][Full Text] [Related]
43. Thromboxane A2 inhibitors and iloprost prevent angiotensin II-induced oedema in the isolated perfused rat lung.
Türker RK; Aksulu HE; Ercan ZS; Aslan S
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):323-9. PubMed ID: 2443097
[TBL] [Abstract][Full Text] [Related]
44. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.
Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S
J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396
[TBL] [Abstract][Full Text] [Related]
45. Role of prostaglandins and thromboxane in the control of renal hemodynamics in experimental liver cirrhosis.
Leehey DJ; Uckerman MT; Rahman MA
J Lab Clin Med; 1989 Mar; 113(3):309-15. PubMed ID: 2926239
[TBL] [Abstract][Full Text] [Related]
46. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade.
Mistry M; Muirhead EE; Yamaguchi Y; Nasjletti A
J Hypertens; 1990 Jan; 8(1):75-83. PubMed ID: 2157760
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandins and the renal responses to haemorrhage, angiotensin II and methoxamine in conscious rabbits.
Bartley PJ; Anderson WP
Clin Exp Pharmacol Physiol; 1984; 11(1):71-80. PubMed ID: 6424989
[TBL] [Abstract][Full Text] [Related]
48. Interaction between renal prostaglandins and angiotensin II in controlling glomerular filtration in the dog.
Olsen ME; Hall JE; Montani JP; Cornell JE
Clin Sci (Lond); 1987 Apr; 72(4):429-36. PubMed ID: 3829591
[TBL] [Abstract][Full Text] [Related]
49. Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney.
Johnston PA; Bernard DB; Perrin NS; Levinsky NG
J Clin Invest; 1981 Jul; 68(1):127-33. PubMed ID: 6788803
[TBL] [Abstract][Full Text] [Related]
50. Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension.
Mistry M; Nasjletti A
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():207-10. PubMed ID: 2526469
[TBL] [Abstract][Full Text] [Related]
51. Renal interstitial hydrostatic pressure and PGE2 in pressure natriuresis.
Gonzalez-Campoy JM; Long C; Roberts D; Berndt TJ; Romero JC; Knox FG
Am J Physiol; 1991 May; 260(5 Pt 2):F643-9. PubMed ID: 2035651
[TBL] [Abstract][Full Text] [Related]
52. Effect of furegrelate on renal plasma flow after angiotensin II infusion.
Kaushal RD; Wilson TW
Can J Physiol Pharmacol; 1990 Apr; 68(4):500-4. PubMed ID: 2328452
[TBL] [Abstract][Full Text] [Related]
53. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats.
Mistry M; Nasjletti A
J Pharmacol Exp Ther; 1990 Apr; 253(1):90-4. PubMed ID: 2139470
[TBL] [Abstract][Full Text] [Related]
54. Renal responses to angiotensin II in conscious dogs: effects of aspirin and indomethacin.
Anderson WP; Selig SE; Woods RL; Gilchrist AI
Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):641-7. PubMed ID: 3440322
[TBL] [Abstract][Full Text] [Related]
55. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure.
Conger JD; Robinette JB; Schrier RW
J Clin Invest; 1988 Aug; 82(2):532-7. PubMed ID: 3261301
[TBL] [Abstract][Full Text] [Related]
56. Regulation of papillary plasma flow by angiotensin II.
Faubert PF; Chou SY; Porush JG
Kidney Int; 1987 Oct; 32(4):472-8. PubMed ID: 3430949
[TBL] [Abstract][Full Text] [Related]
57. Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury.
Bresnahan BA; Dufek S; Wu S; Lianos EA
Kidney Int; 1999 Jan; 55(1):139-47. PubMed ID: 9893122
[TBL] [Abstract][Full Text] [Related]
58. NO mediates downregulation of RBF after a prolonged reduction of renal perfusion pressure in SHR.
Sorensen CM; Leyssac PP; Skott O; Holstein-Rathlou NH
Am J Physiol Regul Integr Comp Physiol; 2003 Aug; 285(2):R329-38. PubMed ID: 12714352
[TBL] [Abstract][Full Text] [Related]
59. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice.
Mederle K; Meurer M; Castrop H; Höcherl K
Am J Physiol Renal Physiol; 2015 Aug; 309(4):F332-40. PubMed ID: 26017977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
